Exportar registro bibliográfico


Metrics:

MATE-1 modulation by kinin B1 receptor enhances cisplatinefflux from renal cells (2017)

  • Authors:
  • Autor USP: CÂMARA, NIELS OLSEN SARAIVA - ICB
  • Unidade: ICB
  • DOI: 10.1007/s11010-016-2920-x
  • Assunto: IMUNOLOGIA
  • Agências de fomento:
  • Language: Inglês
  • Imprenta:
  • Source:
  • Acesso à fonteDOI
    Informações sobre o DOI: 10.1007/s11010-016-2920-x (Fonte: oaDOI API)
    • Este periódico é de assinatura
    • Este artigo NÃO é de acesso aberto
    • Cor do Acesso Aberto: closed

    How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      ESTRELA, Gabriel R.; WASINSKI, Frederick; FELIZARDO, Raphael J. F.; et al. MATE-1 modulation by kinin B1 receptor enhances cisplatinefflux from renal cells. Molecular and Cellular Biochemistry, New York, Springer New York LLC, v. 428, n. 1-2, p. 101-108, 2017. Disponível em: < http://dx.doi.org/10.1007/s11010-016-2920-x > DOI: 10.1007/s11010-016-2920-x.
    • APA

      Estrela, G. R., Wasinski, F., Felizardo, R. J. F., Souza, L. L., Câmara, N. O. S., Bader, M., & Araujo, R. C. (2017). MATE-1 modulation by kinin B1 receptor enhances cisplatinefflux from renal cells. Molecular and Cellular Biochemistry, 428( 1-2), 101-108. doi:10.1007/s11010-016-2920-x
    • NLM

      Estrela GR, Wasinski F, Felizardo RJF, Souza LL, Câmara NOS, Bader M, Araujo RC. MATE-1 modulation by kinin B1 receptor enhances cisplatinefflux from renal cells [Internet]. Molecular and Cellular Biochemistry. 2017 ; 428( 1-2): 101-108.Available from: http://dx.doi.org/10.1007/s11010-016-2920-x
    • Vancouver

      Estrela GR, Wasinski F, Felizardo RJF, Souza LL, Câmara NOS, Bader M, Araujo RC. MATE-1 modulation by kinin B1 receptor enhances cisplatinefflux from renal cells [Internet]. Molecular and Cellular Biochemistry. 2017 ; 428( 1-2): 101-108.Available from: http://dx.doi.org/10.1007/s11010-016-2920-x

    Referências citadas na obra
    Arany I, Safirstein RL (2003) Cisplatin nephrotoxicity. Semin Nephrol 23:460–464
    Miller RP, Tadagavadi RK, Ramesh G, Reeves WB (2010) Mechanisms of Cisplatin nephrotoxicity. Toxins (Basel) 2:2490–2518
    Thadhani R, Pascual M, Bonventre JV (1996) Acute renal failure. N Engl J Med 334:1448–1460
    Morisaki T, Matsuzaki T, Yokoo K, Kusumoto M, Iwata K, Hamada A, Saito H (2008) Regulation of renal organic ion transporters in cisplatin-induced acute kidney injury and uremia in rats. Pharm Res 25:2526–2533
    Yao X, Panichpisal K, Kurtzman N, Nugent K (2007) Cisplatin nephrotoxicity: a review. Am J Med Sci 334:115–124
    Motohashi H, Inui K (2013) Organic cation transporter OCTs (SLC22) and MATEs (SLC47) in the human kidney. Aaps J 15: 581–588.
    Wang L, Sweet DH (2013) Renal organic anion transporters (SLC22 family): expression, regulation, roles in toxicity, and impact on injury and disease. Aaps J 15:53–69.
    Matsuzaki T, Morisaki T, Sugimoto W, Yokoo K, Sato D, Nonoguchi H, Tomita K, Terada T, Inui K, Hamada A, Saito H (2008) Altered pharmacokinetics of cationic drugs caused by down-regulation of renal rat organic cation transporter 2 (Slc22a2) and rat multidrug and toxin extrusion 1 (Slc47a1) in ischemia/reperfusion-induced acute kidney injury. Drug Metab Dispos 36:649–654
    Nies AT, Koepsell H, Damme K and Schwab M (2011) Organic cation transporters (OCTs, MATEs), in vitro and in vivo evidence for the importance in drug therapy. Handb Exp Pharmacol:105–67.
    Ciarimboli G, Lancaster CS, Schlatter E, Franke RM, Sprowl JA, Pavenstadt H, Massmann V, Guckel D, Mathijssen RH, Yang W, Pui CH, Relling MV, Herrmann E, Sparreboom A (2012) Proximal tubular secretion of creatinine by organic cation transporter OCT2 in cancer patients. Clin Cancer Res 18:1101–1108
    Ludwig T, Riethmuller C, Gekle M, Schwerdt G, Oberleithner H (2004) Nephrotoxicity of platinum complexes is related to basolateral organic cation transport. Kidney Int 66:196–202
    Filipski KK, Mathijssen RH, Mikkelsen TS, Schinkel AH, Sparreboom A (2009) Contribution of organic cation transporter 2 (OCT2) to cisplatin-induced nephrotoxicity. Clin Pharmacol Ther 86:396–402
    Kido Y, Matsson P, Giacomini KM (2011) Profiling of a prescription drug library for potential renal drug-drug interactions mediated by the organic cation transporter 2. J Med Chem 54:4548–4558
    Masuda Y, Inoue M, Miyata A, Mizuno S, Nanba H (2009) Maitake beta-glucan enhances therapeutic effect and reduces myelosupression and nephrotoxicity of cisplatin in mice. Int Immunopharmacol 9:620–626
    Otsuka M, Matsumoto T, Morimoto R, Arioka S, Omote H, Moriyama Y (2005) A human transporter protein that mediates the final excretion step for toxic organic cations. Proc Natl Acad Sci USA 102:17923–17928
    Tsuda M, Terada T, Mizuno T, Katsura T, Shimakura J, Inui K (2009) Targeted disruption of the multidrug and toxin extrusion 1 (mate1) gene in mice reduces renal secretion of metformin. Mol Pharmacol 75:1280–1286
    Nakamura T, Yonezawa A, Hashimoto S, Katsura T, Inui K (2010) Disruption of multidrug and toxin extrusion MATE1 potentiates cisplatin-induced nephrotoxicity. Biochem Pharmacol 80:1762–1767
    Marceau F, Bachvarov DR (1998) Kinin receptors. Clin Rev Allergy Immunol 16:385–401
    Regoli D, Barabe J (1980) Pharmacology of bradykinin and related kinins. Pharmacol Rev 32:1–46
    Pereira RL, Buscariollo BN, Correa-Costa M, Semedo P, Oliveira CD, Reis VO, Maquigussa E, Araujo RC, Braga TT, Soares MF, Moura IC, Malheiros DM, Filho AP, Keller AC, Camara NO (2011) Bradykinin receptor 1 activation exacerbates experimental focal and segmental glomerulosclerosis. Kidney Int 79:1217–1227
    Klein J, Gonzalez J, Duchene J, Esposito L, Pradere JP, Neau E, Delage C, Calise D, Ahluwalia A, Carayon P, Pesquero JB, Bader M, Schanstra JP and Bascands JL (2009) Delayed blockade of the kinin B1 receptor reduces renal inflammation and fibrosis in obstructive nephropathy. Faseb J 23:134–142.
    Klein J, Gonzalez J, Decramer S, Bandin F, Neau E, Salant DJ, Heeringa P, Pesquero JB, Schanstra JP, Bascands JL (2010) Blockade of the kinin B1 receptor ameloriates glomerulonephritis. J Am Soc Nephrol 21:1157–1164
    Wang PH, Campanholle G, Cenedeze MA, Feitoza CQ, Goncalves GM, Landgraf RG, Jancar S, Pesquero JB, Pacheco-Silva A, Camara NO (2008) Bradykinin [corrected] B1 receptor antagonism is beneficial in renal ischemia–reperfusion injury. PLoS ONE 3:e3050
    Wang PH, Cenedeze MA, Pesquero JB, Pacheco-Silva A, Camara NO (2006) Influence of bradykinin B1 and B2 receptors in the immune response triggered by renal ischemia–reperfusion injury. Int Immunopharmacol 6:1960–1965
    Estrela GR, Wasinski F, Almeida DC, Amano MT, Castoldi A, Dias CC, Malheiros DM, Almeida SS, Paredes-Gamero EJ, Pesquero JB, Barros CC, Camara NO, Araujo RC (2014) Kinin B1 receptor deficiency attenuates cisplatin-induced acute kidney injury by modulating immune cell migration. J Mol Med (Berl) 92:399–409
    Estrela GR, Wasinski F, Bacurau RF, Malheiros DM, Camara NO, Araujo RC (2014) Kinin B2 receptor deletion and blockage ameliorates cisplatin-induced acute renal injury. Int Immunopharmacol 22:115–119
    Inui KI, Masuda S, Saito H (2000) Cellular and molecular aspects of drug transport in the kidney. Kidney Int 58:944–958
    Pabla N, Dong Z (2008) Cisplatin nephrotoxicity: mechanisms and renoprotective strategies. Kidney Int 73:994–1007
    Pohlen U, Rieger H, Meyer BT, Loddenkemper C, Buhr HJ, Heitland P, Koester HD, Schneider P (2007) Chemoembolization of lung metastases–pharmacokinetic behaviour of carboplatin in a rat model. Anticancer Res 27:809–815

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2020